Clinical Chemistry
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Clinical Chemistry 51: 561-568, 2005. First published January 13, 2005; 10.1373/clinchem.2004.043174
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
clinchem.2004.043174v1
51/3/561    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (10)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by van Geest-Daalderop, J. H.H.
Right arrow Articles by van den Besselaar, A. M.H.P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by van Geest-Daalderop, J. H.H.
Right arrow Articles by van den Besselaar, A. M.H.P.
Related Collections
Right arrow Laboratory Management
Right arrow Hemostasis and Thrombosis
(Clinical Chemistry. 2005;51:561-568.)
© 2005 American Association for Clinical Chemistry, Inc.


Hemostasis and Thrombosis

Preanalytical Variables and Off-Site Blood Collection: Influences on the Results of the Prothrombin Time/International Normalized Ratio Test and Implications for Monitoring of Oral Anticoagulant Therapy

Johanna H.H. van Geest-Daalderop1,a, André B. Mulder1, Leandra J.M. Boonman-de Winter2, Martha M.C.L. Hoekstra3 and Anton M.H.P. van den Besselaar3

1 Thrombosis Service, Department of Laboratory of Clinical Chemistry and Haematology, Jeroen Bosch Hospital, ‘s-Hertogenbosch, The Netherlands.
2 Thrombosis Service and Contract Research, Departments of Stichting Huisartsen Laboratorium, Etten-Leur, The Netherlands.
3 Haemostasis and Thrombosis Research Center, Department of Haematology, Leiden University Medical Center, Leiden, The Netherlands.

aAddress correspondence to this author at: Trombosedienst ‘s-Hertogenbosch, Jeroen Bosch Ziekenhuis, Deutersestraat 2, 5223 GV ’s-Hertogenbosch, The Netherlands. Fax 31-73-6998257; e-mail ankees.vangeest{at}planet.nl.

Background: The quality of oral anticoagulant therapy management with coumarin derivatives requires reliable results for the prothrombin time/International Normalized Ratio (PT/INR). We assessed the effect on PT/INR of preanalytical variables, including ones related to off-site blood collection and transportation to a laboratory.

Methods: Four laboratories with different combinations of blood collection systems, thromboplastin reagents, and coagulation meters participated. The simulated preanalytical variables included time between blood collection and PT/INR determinations on samples stored at room temperature, at 4–6 °C, and at 37 °C; mechanical agitation at room temperature, at 4–6 °C, and at 37 °C; time between centrifugation and PT/INR determination; and times and temperatures of centrifugation. For variables that affected results, the effect of the variable was classified as moderate when <25% of samples showed a change >10% or as large if >25% of samples showed such a change.

Results: During the first 6 h after blood collection, INR changed by >10% in <25% of samples (moderate effect) when blood samples were stored at room temperature, 4–6 °C, or 37 °C with or without mechanical agitation and independent of the time of centrifugation after blood collection. With one combination of materials and preanalytical conditions, a 24-h delay at room temperature or 4–6 °C had a large effect, i.e., changes >10% in >25% of samples. In all laboratories, a 24-h delay at 37 °C or with mechanical agitation had a large effect. We observed no clinically or statistically relevant INR differences among studied centrifugation conditions (centrifugation temperature, 20 °C or no temperature control; centrifugation time, 5 or 10 min).

Conclusions: We recommend a maximum of 6 h between blood collection and PT/INR determination. The impact of a 24-h delay should be investigated for each combination of materials and conditions.




The following articles in journals at HighWire Press have cited this article:


Home page
Clin. Chem.Home page
G. Lippi, G. L. Salvagno, M. Montagnana, G. Poli, and G. C. Guidi
Influence of centrifuge temperature on routine coagulation testing.
Clin. Chem., March 1, 2006; 52(3): 537 - 538.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2005 by the American Association for Clinical Chemistry.